Upstate Active Clinical Trials
Study Title:Allogeneic Hematopoietic Stem Cell Transplatation for CLL, CML, AML, ALL, Myelodysplasia and Non-Hodgkin's Lymphoma after Total Body Irradiation and Cyclophosphamide Conditioning or Cyclophosphamide and ATG Conditioning For Aplastic Anemia.
What is the purpose of the study?To provide allogeneic transplantation for patients with a matched related donor.
Upstate Institutional Review Board (IRB) Number:251022
Study/Protocol ID:BMT 9851
Patient Age Group:Adults
Principal Investigator:Teresa C Gentile, MD, PhD
Who is eligible?Diagnosis of ALL, CLL, CML, AML, Myelodyslasia and Non-Hodgkin's with a matched related donor, acceptable laboratory values, HIV negative, no serious or uncontrolled organ dysfunction.
What is involved if I participate?
- How long is the study?
Inpatient stay approximately 30 days, followed for lifetime.
- Is transportation provided or reimbursed?
- Is parking provided or reimbursed?
- What tests and procedures are involved?
Detailed history & physical to determine eligibility, laboratory tests, x-rays/scans, as necessary, bone marrow biopsy & aspirate as necessary, laboratory tests during hospital admission, dental clearance prior to transplant.
Where will the study take place?SUNY Upstate Medical University,Syracuse, NY
Who can I contact for more information?
Name: Shramika Pokharel, MBBS, MPH